Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure (Q33880241)

29 July 2017

Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure (English)

1 reference

29 July 2017

1 reference

Sophie Jose

1

0 references

Caroline Sabin

object named as

Caroline A Sabin

15

0 references

David Chadwick

12

object named as

David Chadwick

1 reference

29 July 2017

2

Lisa Hamzah

1 reference

29 July 2017

Lucy J Campbell

3

1 reference

29 July 2017

Teresa Hill

4

1 reference

29 July 2017

Martin Fisher

5

1 reference

29 July 2017

Clifford Leen

6

1 reference

29 July 2017

Richard Gilson

7

1 reference

29 July 2017

John Walsh

8

1 reference

29 July 2017

Mark Nelson

9

1 reference

29 July 2017

Phillip Hay

10

1 reference

29 July 2017

Margaret Johnson

11

1 reference

29 July 2017

Dorothea Nitsch

13

1 reference

29 July 2017

Rachael Jones

14

1 reference

29 July 2017

Frank A Post

16

1 reference

29 July 2017

UK Collaborative HIV Cohort Study Steering Committee

17

1 reference

29 July 2017

language of work or name

English

0 references

publication date

28 February 2014

1 reference

Journal of Infectious Diseases

29 July 2017

1 reference

29 July 2017

210

1 reference

29 July 2017

3

1 reference

29 July 2017

363-373

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

29 July 2017

start time

16 January 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The Uncertainty of the eGFR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Association of tenofovir exposure with kidney disease risk in HIV infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Tenofovir-associated renal and bone toxicity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

A new equation to estimate glomerular filtration rate

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Spectrum of chronic kidney disease in HIV-infected patients.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

28 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Fanconi syndrome and renal failure induced by tenofovir: a first case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Predicting tenofovir concentration on the basis of renal factors determined by routine tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Circadian variability of cystatin C, creatinine, and glomerular filtration rate (GFR) in healthy men during normal sleep and after an acute shift of sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Biological variation of cystatin C and creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Intra-individual variation in creatinine and cystatin C

29 October 2018

1 reference

12 December 2020

Assessing recovery of renal function after tenofovir disoproxil fumarate discontinuation

1 reference

12 December 2020

1 reference

12 December 2020

Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2

1 reference

12 December 2020

Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir

1 reference

12 December 2020

Identifiers

DOI

10.1093/INFDIS/JIU107

1 reference

29 July 2017

1 reference

29 July 2017

1 reference